NCT05184153

Brief Summary

Retrospective cohort of 10 cases of colonic adenocarcinoma of medullary type, operated between 2000 and 2020 at the University Hospital of Limoges. Collection of relevant data for this rare entity. Subgroup analysis in search of prognostic factors. Comparison of the data from our cohort with those from the literature.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
Last Updated

January 11, 2022

Status Verified

September 1, 2021

Enrollment Period

10 months

First QC Date

October 28, 2021

Last Update Submit

January 7, 2022

Conditions

Medullary Carcinoma of ColonPrognostic FactorsSurvival Analysis

Keywords

Medullary Carcinoma of Colonprognostic factorssurvival analysis

Outcome Measures

Primary Outcomes (1)

  • Survival

    Number of days between diagnosis and death

    Through study completion in April 2021

Secondary Outcomes (1)

  • Progression

    Through study completion in April 2021

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with an anatomopathological diagnosis of colorectal adenocarcinoma of medullary type managed at the chu de Limoges between 2000 and 2020

You may qualify if:

  • Pathological diagnosis of colorectal adenocarcinoma of medullary type between 2000 and 2020

You may not qualify if:

  • Absence of anatomopathological confirmation on the surgical specimen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Chirurgie Digestive et Endocrinienne du CHU de Limoges

Limoges, 87045, France

Location

Study Officials

  • Niki CHRISTOU, Dr

    0 33 5 55 05 67 30

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2021

First Posted

January 11, 2022

Study Start

March 3, 2020

Primary Completion

December 19, 2020

Study Completion

September 1, 2021

Last Updated

January 11, 2022

Record last verified: 2021-09

Locations

FR(1)